Lim, Y. L., Kim, M. Y., Jang, Y. O., Baik, S. K., & Kwon, S. O. (2017). Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study. Gut Liver.
Chicago Stili AlıntıLim, Yoo Li, Moon Young Kim, Yoon Ok Jang, Soon Koo Baik, ve Sang Ok Kwon. "Rifaximin and Propranolol Combination Therapy Is More Effective Than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study." Gut Liver 2017.
MLA AlıntıLim, Yoo Li, et al. "Rifaximin and Propranolol Combination Therapy Is More Effective Than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study." Gut Liver 2017.